Editorial: Drug repurposing for cancer treatment: current and future directions

Editorial: Drug repurposing for cancer treatment: current and future directions

Saved in:

Bibliographic Details
Main Authors:	Marios Lampros, Nikolaos Vlachos, Georgios D. Lianos, Christina Bali, George A. Alexiou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	antipsychotics - treatment cancer treatment gastrointestinal cancer glioblastoma chemotherapy agents
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1550672/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Applications of polymeric nanoparticles in drug delivery for glioblastoma
by: Shuhan Liu, et al.
Published: (2025-01-01)

Trifluridine-tipiracil in previously treated patients with oestrogen receptor-positive, HER2-negative metastatic breast cancer (BOOG 2019-01 TIBET trial): a single-arm, multicentre, phase 2 trialResearch in context
by: Niels A.D. Guchelaar, et al.
Published: (2025-02-01)

Peculiarities of personalized selection of antipsychotic drugs for schizophrenia treatment
by: O.O. Khaustova, et al.
Published: (2024-04-01)

Safety assessment of preventive pressurized intraperitoneal aerosol chemotherapy in combined treatment of gastric cancer: preliminary results
by: N. Ya. Muratova, et al.
Published: (2024-03-01)

Non-pharmacological therapies in the treatment of chemotherapy-induced alopecia – a literature review
by: Izabela Ochonska, et al.
Published: (2025-01-01)

Exploring the role of artificial intelligence in chemotherapy development, cancer diagnosis, and treatment: present achievements and future outlook
by: Bassam Abdul Rasool Hassan, et al.
Published: (2025-02-01)

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
by: Miquel Bernardo, et al.
Published: (2025-01-01)

Preoperative immunochemotherapy versus chemotherapy as first-line treatment for patients with stage I–IIIB small-cell lung cancer
by: Linhai Zhu, et al.
Published: (2025-01-01)

Impact of Bone-Modifying Agents on Post-Bone Metastasis Survival Across Cancer Types
by: Hironari Tamiya, et al.
Published: (2025-01-01)

On the MTD paradigm and optimal control for multi-drug cancer chemotherapy
by: Urszula Ledzewicz, et al.
Published: (2013-03-01)

Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments
by: Edgar Yebran Villegas-Vazquez, et al.
Published: (2025-01-01)

Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study
by: Zhouwei Zhan, et al.
Published: (2025-02-01)

Association between a publicly funded universal drug program and antipsychotic and antidepressant medication dispensing to children
by: Sophie A. Kitchen, et al.
Published: (2025-02-01)

A cross-sectional study to analyze the pattern of pharmacotherapy and its associated factors among patients with schizophrenia
by: B. S. Abhishree, et al.
Published: (2024-12-01)

Virosome, a hybrid vehicle for efficient and safe drug delivery and its emerging application in cancer treatment
by: Liu Hanqing, et al.
Published: (2015-06-01)

Personalising glioblastoma medicine: explant organoid applications, challenges and future perspectives
by: Niclas Skarne, et al.
Published: (2025-01-01)

Reversal gene expression assessment for drug repurposing, a case study of glioblastoma
by: Shixue Sun, et al.
Published: (2025-01-01)

The interpretation of Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update
by: LU Yujie, ZHU Siji
Published: (2024-09-01)

Antipsychotic-induced hyperprolactinemia: Toxicologic mechanism and the increased breast cancer risk
by: Steven B. Bird
Published: (2025-06-01)

Effects of Potentially Inappropriate Medications in Older Patients with Gastrointestinal System Cancer
by: Melike OZKAN, et al.
Published: (2023-12-01)

Dynamics and control of a mathematical model for metronomic chemotherapy
by: Urszula Ledzewicz, et al.
Published: (2015-07-01)

Thermal ablation included in multimodality treatment predicts enhanced survival in advanced non-small cell lung cancer: a propensity score-matched outcome study
by: Stella Chin-Shaw Tsai, et al.
Published: (2025-12-01)

Nanoparticles assisted drug delivery for effective management of Glioblastoma
by: Mansi Damani, et al.
Published: (2025-01-01)

PARP inhibitors in the treatment of Pancreatic Cancer - A Review of literature
by: Jagoda Niewiadomska, et al.
Published: (2025-01-01)

Evaluating survival outcomes and treatment recommendations in resectable gastric cancer
by: Saad Sabbagh, et al.
Published: (2025-01-01)

Inferior mesenteric artery skeletization with para-aortic lymphadenectomy in the treatment of left-sided colon cancer
by: P. V. Tsarkov, et al.
Published: (2012-04-01)

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
by: Michael Ghadimi, et al.
Published: (2025-02-01)

Metformin as an adjuvant option for systemic treatment of breast cancer
by: D.I. Avierin, et al.
Published: (2023-12-01)

The neuroscience in breast cancer: Current insights and clinical opportunities
by: Jia-feng Wang, et al.
Published: (2025-02-01)

Neurocognitive function and health-related quality of life among glioblastoma patients: A prospective study
by: Mohamed A Baba, et al.
Published: (2025-01-01)

Autophagy in brain tumors: molecular mechanisms, challenges, and therapeutic opportunities
by: Jiarui Zhang, et al.
Published: (2025-01-01)

Overview of Novel Antipsychotic Drugs: State of the Art, New Mechanisms, and Clinical Aspects of Promising Compounds
by: Letizia Biso, et al.
Published: (2025-01-01)

Significance of non-steroidal anti-inflammatory drugs in the prevention and treatment of cervical cancer
by: Xun Kan, et al.
Published: (2025-02-01)

Characterization of tumor prognosis and sensitive chemotherapy drugs based on cuproptosis-related gene signature in ovarian cancer
by: Wei Tan, et al.
Published: (2025-01-01)

PARP Inhibitors in the Treatment of Ovarian Cancer
by: Andrzej Paweł Zuzak, et al.
Published: (2025-02-01)

Cytotoxic activity of Fomitopsis betulina against normal and cancer cells – a comprehensive literature review
by: Paulina Nowotarska, et al.
Published: (2024-10-01)

Therapeutic drug monitoring of atypical antipsychotic drugs
by: Grundmann Milan, et al.
Published: (2014-12-01)

The use of Kutikulin for treatment and prevention of gastrointestinal diseases in calves and piglets
by: M. V. Koryukina, et al.
Published: (2022-06-01)

A Prospective, Observational Study on Adverse Drug Reactions in Hospitalized Pediatric Cancer Patients in a Tertiary Care Teaching Hospital
by: Nancy Khajuria, et al.
Published: (2024-12-01)

A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models
by: Anders H. Hansen, et al.
Published: (2025-01-01)